Immunology of acetylcholine receptors in relation to myasthenia gravis.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Physiological Reviews

• Publication date

  1980-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/PHYSREV.1980.60.3.756PMID 6248907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The density of cholinergic receptors at the endplate postsynaptic membrane: Ultrastructural studies in two mammalian species

  2005cited by this paper
• Passively transferred experimental autoimmune myasthenia gravis

  1979cited by this paper
• Antibodies to motor endplates demonstrated with the immunofluorescence technique.

  1979cited by this paper
• Long-term effects of repeated plasma exchange in myasthenia gravis.

  1979cited by this paper
• Cellular immunity to acetylcholine receptor in myasthenia gravis

  1979cited by this paper
• The immunological effects of thymectomy in myasthenia gravis.

  1979cited by this paper
• Acetylcholine receptors in organ-cultured human muscle fibres

  1979cited by this paper
• Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.

  1979cited by this paper
• Absence of anti-acetylcholine receptor antibodies in congenital myasthenia gravis.

  1979cited by this paper
• Humoral immunity before and after thymectomy in myasthenia gravis

  1979cited by this paper
• Myasthenia gravis (first of two parts).

  1978cited by this paper
• Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.

  1978cited by this paper
• Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera

  1978cited by this paper
• Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.

  1978cited by this paper
• Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor.

  1978cited by this paper
• Binding of antibodies to acetylcholine receptors in Electrophorus and Torpedo electroplax membranes

  1978cited by this paper
• Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.

  1978cited by this paper
• Acetylcholine Receptor Antibody in Myasthenia Gravis: Purification and Characterization

  1978cited by this paper
• Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis.

  1978cited by this paper
• Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.

  1978cited by this paper
• MYASTHENIA GRAVIS IN PATIENTS WITH THYMOMA, WITH PARTICULAR REFERENCE TO ONSET AFTER THYMECTOMY

  1978cited by this paper
• Skeletal muscle acetylcholine receptor. Purification, characterization, and turnover in muscle cell cultures.

  1978cited by this paper
• Nonequivalence of alpha-bungarotoxin receptors and acetylcholine receptors in chick sympathetic neurons.

  1978cited by this paper
• The acetylcholine receptor as part of a protein complex in receptor-enriched membrane fragments from Torpedo californica electric tissue.

  1978cited by this paper
• Acetylcholine-induced channels and transmitter release at human endplates

  1978cited by this paper
• Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum.

  1978cited by this paper
• Acetylcholine-induced conductance fluctuations in cultured human myotubes

  1978cited by this paper
• Clinical syndromes of myasthenia in infancy and childhood. A review.

  1978cited by this paper
• Function of circulating antibody to acetylcholine receptor in myasthenia gravis

  1978cited by this paper
• Composition of acetylcholine receptor protein from skeletal muscle

  1978cited by this paper
• HLA and neurologic disease

  1978cited by this paper
• Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor

  1978cited by this paper
• Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.

  1978cited by this paper
• Specificities of antibodies to acetylcholine receptors

  1978cited by this paper
• Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.

  1978cited by this paper
• Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.

  1978cited by this paper
• Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions.

  1978cited by this paper
• Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.

  1978cited by this paper
• Acetylcholine receptor and ionic channel of Torpedo electroplax: binding of perhydrohistrionicotoxin to membrane and solubilized preparations.

  1978cited by this paper
• Penicillamine‐induced myasthenia gravis associated with antibodies to acetylcholine receptor

  1978cited by this paper
• Localization of acetylcholine receptor in excitable membrane from the electric organ of Torpedo: Evidence for exposure of receptor antigenic sites on both sides of the membrane.

  1978cited by this paper
• Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

  1978cited by this paper
• Neonatal experimental autoimmune myasthenia gravis

  1978cited by this paper
• Serum factor blocks neuromuscular transmission in myasthenia gravis

  1978cited by this paper
• Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.

  1978cited by this paper
• Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle.

  1978cited by this paper
• Role of virus for the induction of myasthenia gravis.

  1978cited by this paper
• Acetylcholine-receptor antibody in cerebrospinal fluid.

  1978cited by this paper
• No significant correlation of HLA-B8 and amount of antibodies directed to acetylcholine receptor protein in patients with myasthenia gravis.

  1978cited by this paper
• Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.

  1978cited by this paper
• Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.

  1978cited by this paper
• Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle

  1978cited by this paper
• Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure.

  1978cited by this paper
• Serum antibodies to cytomegalovirus in myasthenia gravis

  1978cited by this paper
• In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis.

  1978cited by this paper
• Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

  1978cited by this paper
• Distinct protein components from Torpedo marmorata membranes carry the acetylcholine receptor site and the binding site for local anesthetics and histrionicotoxin.

  1978cited by this paper
• Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton‐Lambert syndrome

  1978cited by this paper
• A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.

  1977cited by this paper
• Cytophilic antibodies in experimental autoimmune myasthenia gravis.

  1977cited by this paper
• A note on the structure of immunized endplates

  1977cited by this paper
• Acetylcholine receptor: ‐SH group reactivity as indicator of conformational changes and functional states

  1977cited by this paper
• Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism.

  1977cited by this paper
• An analysis of acetylcholine in frog muscle by mass fragmentography

  1977cited by this paper
• Myasthenia gravis: acetylcholine-receptor antibody titres after thymectomy.

  1977cited by this paper
• Subunit structure of the acetylcholine receptor from denervated rat skeletal muscle.

  1977cited by this paper
• Intrathymic pathogenesis and dual genetic control of myasthenia gravis.

  1977cited by this paper
• Is there acetylcholine receptor in human thymus?

  1977cited by this paper
• Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.

  1977cited by this paper
• Postsynaptic membranes in the electric tissue of Narcine: I. Organization and innervation of electric cells. Fine structure of nicotinic receptor-channel molecules revealed by transmission microscopy.

  1977cited by this paper
• HLA antigens and myasthenia gravis in Japan.

  1977cited by this paper
• Binding of alpha-bungarotoxin and cholinergic ligands to acetylcholine receptors in the membrane of skeletal muscle.

  1977cited by this paper
• Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.

  1977cited by this paper
• STIMULATION OF LYMPHOCYTES BY CHOLINERGIC RECEPTOR IN MYASTHENIA GRAVIS

  1977cited by this paper
• Thymic epithelial cell contains acetylcholine receptor.

  1977cited by this paper
• Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

  1977cited by this paper
• Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

  1977cited by this paper
• Anti-acetylcholine receptor antibody in neonatal myasthenia gravis.

  1977cited by this paper
• Postsynaptic membranes in the electric tissue of Narcine: IV. Isolation and characterization of the nicotinic receptor protein.

  1977cited by this paper
• Binding of perhydro-histrionicotoxin to the postsynaptic membrane of skeletal muscle in relation to its blockage of acetylcholine-induced depolarization.

  1977cited by this paper
• Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons.

  1977cited by this paper
• Assessment of cellular and humoral immunity of myasthenics.

  1977cited by this paper
• ULTRASTRUCTURAL LOCALIZATION OF IMMUNE COMPLEXES (IgG and C3) AT THE END‐PLATE IN EXPERIMENTAL AUTOMMUNE MYASTHENIA GRAVIS

  1977cited by this paper
• D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis.

  1977cited by this paper
• Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

  1977cited by this paper
• Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.

  1977cited by this paper
• Long-term effect of glucocorticosteroids on neuromuscular blocking in mice.

  1977cited by this paper
• Possible regulatory function of acetylcholine receptor in maintenance of retinotectal synapses

  1977cited by this paper
• Affinity alkylation labels two subunits of the reduced acetylcholine receptor from mammalian muscle.

  1977cited by this paper
• Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.

  1977cited by this paper
• Immunochemical studies on acetylcholine receptor from Torpedo californica.

  1977cited by this paper
• Modulation of acetylcholine receptor by antibody against the receptor.

  1977cited by this paper
• Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.

  1977cited by this paper
• Structural studies of a membrane-bound acetylcholine receptor from Torpedo californica.

  1977cited by this paper
• Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis

  1977cited by this paper
• Perhydrohistrionicotoxin: a potential ligand for the ion conductance modulator of the acetylcholine receptor.

  1977cited by this paper
• Immunological comparison of acetylcholine receptors and their subunits from species of electric ray.

  1977cited by this paper
• Molecular forms of acetylcholine receptor. Effects of calcium ions and a sulfhydryl reagent on the occurrence of oligomers.

  1977cited by this paper
• Acetylcholine receptor protein. Neuromuscular transmission in immunized rabbits.

  1977cited by this paper
• Central nervous-system involvement in experimental autoimmune myasthenia gravis.

  1977cited by this paper

• Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinoma.

  2025cites this paper
• Myasthenia research over the last 50 years – a personal perspective

  2023cites this paper
• The Future of Myasthenia Gravis: Exploring the Onset, Progression and Implications of Disease

  2016cites this paper
• Dual roles for an intracellular calcium-signaling pathway in regulating synaptic homeostasis and neuronal excitability

  2015cites this paper
• Receptor Expression: Implications for Effects of Cytokines on Acetylcholine

  2013cites this paper
• Hormone Resistance and Other Endocrine Paradoxes

  2011cites this paper
• Biological implications of thymectomy for myasthenia gravis

  2010cites this paper
• Paraneoplastic neurological disorders

  2010cites this paper
• Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis

  2008cites this paper
• [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].

  2008cites this paper
• IL-2 and proteoglycans synergistically induce antigen-specific B-cell responses--a possible immune response in the hyperplastic myasthenia thymus.

  2008cites this paper
• Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs

  2005cites this paper
• Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis 1

  2005cites this paper
• Effect of diazepam on muscle weakness in a model of myasthenia gravis in rats

  2005cites this paper
• Anti-idiotype and anti-hormone receptor antibodies

  2005cites this paper
• Effect of estradiol and progesterone on muscle weight and acetylcholine receptors in “myasthenic” rats

  2005cites this paper
• EFFECTOR MECHANISMS IN MYASTHENIA PASSIVE TRANSFER OF IgG, Fab, AND F(ab’), HYBRID MOLECULES GRAVIS: END-PLATE FUNCTION AFTER

  2004cites this paper
• The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.

  2003cites this paper
• Immunotherapeutic approaches to paraneoplastic neurological disorders

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• The potential role of bcl-2 , bax , and Ki 67 expression in thymus of patients with myasthenia gravis , and their correlation with clinicopathologic parameters q

  2001cites this paper
• Serum Anti-Acetylcholine Receptor Antibodies And Sensitivity to Vecuronium in Patients with Myasthenia Gravis

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Expression of ciliary neurotrophic factor receptor in myasthenia gravis.

  2001cites this paper
• Modulation of acetylcholine receptor expression in seronegative myasthenia gravis

  2000cites this paper
• Immunotherapeutic approaches to paraneoplastic neurological disorders

  2000cites this paper
• Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats

  1999cites this paper
• Protection of immunoreactivity of dry immobilized proteins on microtitration plates in ELISA: application for detection of autoantibodies in myasthenia gravis.

  1999cites this paper
• Genetic and antibody-mediated channelopathies at the neuromuscular junction.

  1999cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  1998cites this paper
• Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels

  1998cites this paper
• IL‐12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody‐ mediated disease

  1998cites this paper
• Antibodies Affecting Ion Channel Function in Acquired Neuromyotonia, in Seropositive and Seronegative Myasthenia Gravis, and in Antibody‐mediated Arthrogryposis Multiplex Congenita

  1998cites this paper
• Identification of haemopoietic biglycan in hyperplastic thymus associated with myasthenia gravis.

  1998cites this paper
• Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.

  1998cites this paper
• Acquired slow–channel syndrome: A form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel

  1998cites this paper
• Disorders of the Human Neuromuscular Junction

  1997cites this paper
• Thymoma and Autoimmune Neurological Disorders

  1997cites this paper
• Immunotherapy in neuromuscular disorders: Current and future strategies

  1996cites this paper
• Signs in ocular myasthenia and pseudomyasthenia Differential diagnostic criteria: A clinical review

  1995cites this paper
• Acetylcholine release in myasthenia gravis: Regulation at single end‐plate level

  1995cites this paper
• In vivo preferential usage of TCR V/gb8 in Torpedo acetylcholine receptor immune response in the murine experimental model of myasthenia gravis

  1995cites this paper
• Autoantibodies, neurotoxins and the nervous system.

  1995cites this paper
• Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parameters

  1995cites this paper
• Response to human acetylcholine receptor alpha 138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits.

  1994cites this paper
• Immunomodulation of experimental autoimmune myasthenia gravis with linomide.

  1994cites this paper
• Passive transfer of seronegative myasthenia gravis to mice

  1994cites this paper
• Studies of IgG-class anticardiolipin antibodies in myasthenia gravis.

  1994cites this paper
• β-Bungarotoxin binding protein is immunogenic but lacks myasthenogenicity in rats

  1994cites this paper
• Detection of anti‐acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line

  1994cites this paper
• [Desensitization of the nicotinic acetylcholine receptor].

  1994cites this paper
• Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

  1994cites this paper
• Specific immune complexes augment in vitro acetykholine receptor‐specific T‐cell proliferation

  1993cites this paper
• A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravis a

  1993cites this paper
• Ocular myasthenia gravis

  1993cites this paper
• Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits.

  1993cites this paper
• Influence of Immunological Fine‐specificity on the Induction of Experimental Myasthenia Gravis a

  1993cites this paper
• Thymus Histology and Acetylcholine Receptor Antibodies in Generalized Myasthenia Gravis

  1993cites this paper
• The β2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG)

  1993cites this paper
• Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.

  1993cites this paper
• The hu‐SCID Myasthenic Mouse: A New Tool for the Investigation of Seronegative Myasthenia Gravis a

  1993cites this paper
• Inhibition of myosin ATPase activity by human myasthenia gravis antibodies reactive with the acetylcholine receptor

  1993cites this paper
• Primary structure of the human muscle acetylcholine receptor

  1993cites this paper
• Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.

  1993cites this paper
• Pathogenic autoimmunity to affinity‐purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice

  1993cites this paper
• Strategies for Treatment of Myasthenia Gravis a

  1993cites this paper
• Correlation between the number of TH 1-like cell clones from peripheral blood lymphocytes of childhood myasthenia gravis patients and the recurrence or excerabation of clinical signs

  1993cites this paper
• Antibodies to brain integral membrane proteins in systemic lupus erythematosus.

  1993cites this paper
• The human–severe combined immunodeficiency myasthenic mouse model: A new approach for the study of myasthenia gravis

  1993cites this paper
• Antigen presentation and T cell specificity repertoire in determining responsiveness to an epitope important in experimental autoimmune myasthenia gravis.

  1993cites this paper
• Myasthenia gravis: An autoimmune response against the acetylcholine receptor

  1993cites this paper
• Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha‐bungarotoxin‐treated rats.

  1992cites this paper
• Experimental autoimmune myasthenia gravis : target organ resistance and immunogenetics

  1992cites this paper
• Repetitive nerve stimulation vs. twitch tension in rats with EAMG

  1992cites this paper
• Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patients.

  1992cites this paper
• Ten years experience with therapeutic apheresis in a community hospital

  1992cites this paper
• Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma

  1992cites this paper
• Seronegative generalized myasthenia gravis

  1992cites this paper
• Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.

  1992cites this paper
• Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravis.

  1992cites this paper
• Immunointervention with cyclosporin A in autoimmune neurological disorders.

  1992cites this paper
• Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: subsetting of serum antibodies by preparative isoelectric focusing.

  1992cites this paper
• Subsetting of acetylcholine receptor-reactive antibodies by preparative isoelectric focusing.

  1991cites this paper
• In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis

  1991cites this paper
• Seronegative myasthenia gravis: A plasma factor inhibiting agonist‐induced acetylcholine receptor function copurifies with IgM

  1991cites this paper
• Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.

  1991cites this paper
• Mathematical Modeling of Antigen and Immune Complex Kinetics during Extracorporeal Removal of Autoantibody

  1991cites this paper
• Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.

  1991cites this paper
• Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance.

  1991cites this paper
• Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.

  1990cites this paper
• A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro

  1990cites this paper
• Myasthenia gravis: prototype of the antireceptor autoimmune diseases.

  1990cites this paper
• The human muscle nicotinic acetylcholine receptor alpha‐subunit exist as two isoforms: a novel exon.

  1990cites this paper
• Ontogenic characterization of thymic B lymphocytes. Analysis in different mouse strains

  1990cites this paper
• Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients

  1990cites this paper
• Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.

  1990cites this paper
• The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis

  1990cites this paper
• Synaptic adaptation in diseases of the neuromuscular junction.

  1990cites this paper